Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

New drugs are improving treatment for hormone-related diseases in small pets.

Poor maternal nutrition can lead to fewer wool follicles in Chinese Merino sheep.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

High levels of the seizure medication sodium valproate can cause hair loss.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride helps protect brain in old male rats.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Hair regrowth doesn't convert thin hairs to thick hairs, but increases overall hair density.